4:13 pm Medivation: Astellas confirms marketing approval in Japan for XTANDI (enzalutamide) capsules, an advanced prostate cancer treatment
View todays social media effects on MDVN
View the latest stocks trending across Twitter. Click to view dashboard
See who Medivation is hiring next, click here to view
